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Conclusion: There is a significant variation in measured atrial DFT with a nadir in the 
morning. This is the converse lo measurements of ventricular DFTs suggesting different 
regulatory electrophysiological mechanisms. 
1139-18 Linearity of Myocardial Electric Field With Respect to 
Transthoracic Current 
0. Carlton Deals, Bruce 8. Lerman Cornell University Medical Center, New York, NY 
Background: When myocardial electric fields produced by transthoracic defibrillation 
shocks are modeled using the finite element method. it is generally assumed that tissue 
conductivity is independent of the applied voltage and current. This assumption implies a 
linear relation between the electric field magnitude and transthoracic current, which has 
not been verified experimentally. We conducted a study lo assess the hypothesis that the 
myocardial electric field is a linear function of transthoracic current. 
Methods: In each of 6 dogs, 5 calibrated single-plunge triaxial electrode arrays were 
placed in the left ventricle. The signal cables from the arrays wars externalized through 
the median sternotomy and connected to the data acquisition system. Shocks ware deliv- 
ered through external stainless steel electrodes with a constant 50.newton force applied. 
The defibrillator was discharged through a current divider that allowed precise selection 
of the delivered current. Six shocks ware delivered at IO-minute intervals over a range of 
14 lo 38 amperes. Before each shock, the heart was fibrillated for IO seconds. The total 
sample size for each dog therefore consisted of 6 shocks for each of 5 sites. Data were 
analyzed by first extracting the peak value of each damped-sinusoidal pulse using a mul- 
tiple regression curve fit. Then, for each dog, linear regression was performed for the 
electric field magnitude at each site versus the 6 values of transthoracic current, and the 
correlation coefficient (I) was calculated. The mean and standard deviation ware then 
calculated for rover the 30 total sites. 
Resulb: The range of r was 0.870 to 0.999. The corresponding mean and standard devi- 
ation of r were 0.970 and 0.035, respectively. At 41% of the sites, r was greater than 
0.990. 
Conclusions: These results validate the hypothesized linear relation between the myo- 
cardial electric field magnitude and transthoracic current. These findings are important 
for verification of numerical defibrillation models using results from experimental mea- 
surements. 
1139-19 Safety and Feasibility of Dobutamina-Atropine Stress 
Echocardiography for the Evaluation of Myocardial 
lschemia in Patients With Implantable Cardioverter 
Defibrillators 
Abdou Elhendy. John Wmdle, Bradley Peterson, Thomas R. Porter, University of 
Nebraska Medical Center, Omaha, NE 
Background. Coronary artery disease is the underlying etiology of kfl ventricular dys- 
function and arrhythmias in the majority of patients receiving implantable cardloverler 
defibrillator (ICD). In most laboratories, patients at high risk of ventricular arrhythmias are 
excluded from dobutamine stress echocardiography (DSE) due to the arrhythmogenic 
effect of dobutamine. The aim of this study was to assess safely and feasibility of DSE in 
patients with ICD. 
Methods. DSE (dobutamine up to 50 pglkglmin-atropine up lo 2 mg) was performed in 85 
patients with ICD and known or suspected coronary artery disease. The ICD was inacti- 
vated prior to the stress test and reactivated after the study. lschemia was defined as 
new or worsening wall motion abnormality. A feasible study was defined as achievement 
of the target hearl rate (265% of maximal heart rate predicted for age) and/or an ischemic 
endpoint (angina, ST segment depression or reversible wall motion abnormality). 
Results. Mean age was 67r 11 years (60 men). Mean ejection fraction was 32 * IO %. 
Regional wall motion abnormalities were detected in 78 (92%) patients at rest. No death, 
myocardial infarction or sustained ventricular arrhythmias occurred during the DSE. Non- 
sustained ventricular tachycardia occurred in 6 (7%) patients and supraventricular tachy- 
cardia occurred !n 1 patient (1%). Episodes were termmated spontaneously. by termina- 
tion of the test or by administration of intravenous metoprolol. The target heart rate was 
achieved in 75 (135%) pabents. DSE was positive for ischemia in 30 (35%) pa&n@. 
Angina occurred in 9 (11%) patients and ST-segment depresslon occurred in 14 (16%) 
patients. The test was considered feasible in 81 (95%) patients. 
Conclusion. DSE is a safe and feasible method for evaluation of myocardial ischemia in 
patients with ICD and depressed ejection fraction. 
1139-20 Outcomes and Shock Experience of Implantable 
Cardioverter Defibrillator Patients on Chronic 
Hemodialysis 
Ravi K. Yarlaaadda Dan&e C. Guertin, Christopher A. Clyne. Jeffrey Kluger, Hartford 
Hospital, Hartford, CT 
Background: The Implantable Cardioverter Defibrillator (ICD) is highly effective in termi- 
nating VTNF and in aborting sudden cardiac death @CD). The occurrence of VTNF in 
ESRD patients on hemodialysis (HD) is common and occur during HD and between 
treatments. During HD, the incidence of arrhythmias is enhanced because of rapid fluctu- 
ations in hemodynamics and electrolyte concentrations, especially in patients with a high 
incidence of myocardial disease. Studies examining the role of potassium in dialysis- 
induced arrhythmias found a correlation between changes in the plasma potassium con- 
centration during dialysis and the incidence of arrhythmias. Consequently, we sought lo 
determine the outcome and shock experience of ICD patients on chronic HD. Methods/ 
Resuks: We reviewed a prospectively collected ICD patient database and the charts of 
the ICD patients who were on chronic HD secondary to ESRD. Out of 424 ICD patients 
implanted at our institution from 1995 to 2002, 11(2.5%) were on HD. The mean age of 
this group was 60.9+ 6 years. The mean EF was 24%* 8. Five patients had ischemic car- 
diomyopathy while the remainder had non-lschemic cardiomyopathy. Seven out of these 
11 patients received ICD shocks. There were 7 cluster shocks (>3 shocks in 24 hours) in 
5 out of 11 (45.4%) patients due lo VT storm. The incidence of cluster shocks in our gen- 
eral ICD population is 48 out of 424 (I 1.3%)[p=O.O006]. The cluster shocks occurred dur- 
ing dialysis therapy using low potassium baths and resolved with potassium 
supplementation. One dialysis patient had the ICD removed because of MRSA bactere- 
mia. Three of these 11 patients died within one year of implant (27%) while 59 out of 424 
general ICD patients died (13.9%)[p=O.43]. Conclusion: ICD patients on chronic HD are 
more likely to have cluster shocks secondary to VT storm compared to the general ICD 
population. This appears entirely due to electrolyte solutions during dialysis and is arne- 
nabk to correction with altered dialysis fluids. To reduce the risk of adverse arrhythmic 
events during HD, the dialysate prescription should be evaluated and modified for ICD 
oatients. 
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834-1 Elevated C-Reactive Protein Predicts Pulmonary Vein 
Narrowing Following Pulmonary Vein Ablation of Atrial 
Fibrillation 
Mohammad Alahoul Nassir F. Marrouche, David 0. Marlin, Robed Schweikert, Walid 
Saliba, Raed H. Abdelhadi, Alejandro Perez-Lugones, Ahmad Abdul-Karim, Oussama 
Wazni, Andrea Natale, The Cleveland Clinic Foundation, Cleveland, OH 
Background: Elevated C-reactive protein (CRP) has recently been associated with the 
occurrence of atrial fibrillation (AF). suaaestina an inflammatorv basis of AF. Pulmonalv -_ - 
vein stenosis after pulmonary vein ablation (PVA) may also be related to inflammation. In 
this studv. we tested the hvoothesis that elevated CRP oredicts AF recurrence and oul- 
monary vein narrowing following PVA of AF. Methods: The study sample consisted of 
130 consecutive patients undergoing PVA at our institution from September 2001 to June 
2002. Ultrasensitive serum CRP was measured prior to the procedure and at 3-month 
follow-up. All patients were followed for AF recurrence using transtelaphonic monitoring. 
Early AF recurrence was defined as AF within 6 weeks of ablation and late recurrence 
was defined as AF occurring after 6 weeks. All patients had a chest CT at 3-month fol- 
low-up to evaluate pulmonary vein stenosis, which was graded as none, mild (c50%), 
moderate (50.70%), or severe (>70%). Results One hundred and twenty patients had 
CRP drawn prior to the ablation. and at follow-up. Neither baseline CRP or follow-up 
CRP was associated with early or late AF recurrence (P>0.2 for all comparisons). The 
mean baseline CRP was significantly higher (0.72 vs 0.34 mgldl, PcO.03) in the 21 
patients who developed PV narrowing (mild in 22 and moderate in 10) than in those who 
did not. The follow-up CRP was also higher in patients who developed PV narrowing 
(0.48 vs 0.27 mgldl, P=O.O3). Conclusions: In this study, elevated CRP predIcted the 
subsequent occurrence of PV narrowing, but did not predict the occurrence of either 
early or late AF following ablation to isolate the pulmonary veins. These resulb suggest 
that patients with an active inflammatory state may be at higher risk of developing PV 
stenosis, possibly due lo the direct interaction between inflammatory mediators and tis- 
sue damaged by ablation. 
